Table 1.

Baseline demographic and medical characteristics and urodynamic parameters of study participants.

Demographic and Medical Characteristics	566729		399343		955941		535144		25801		151947		573487
Gender	Male		Female		Female		Female		Male		Male		Male
Age (years)	32		49		43		32		48		38		28
Years since injury	1.25		5.67		3.08		2.08		1.00		23		3.56
Level of injury	T4		C6		T11		T6		C3		T6		T8
ASIA classification	A		B		C		A		C		A		A
Bladder Management	CIC		CIC		CIC		CIC		CIC		CIC		CIC
LUT Sensation	No		Yes		Yes		Yes		No		Yes		Yes
Urinary incontinence	One episode per day		None		Rare		One episode per week		Multiple times a day		None		Few episodes per week
LUT medications	None		Fesoterodine 8 mg Daily		Oxybutynin ER 15 mg Daily		Mirabegron 50 mg Daily		None		Onabotinum toxin		None
Bowel regimen	Sup/DS		Sup/DS		Enema/DS		DS		DS		Sup/DS		DS
Autonomic dysreflexia	No		Yes		No		Yes		Yes		No		No
LUT Characteristics	TESSLA		TESSLA		TESSLA		TESSLA		TESSLA		TESSLA		TESSLA
	Off	On	Off	On	Off	On	Off	On	Off	On	Off	On	Off	On
Vol at first detrusor contraction (ml)	205	281	164	160	356	500	71	212	87	198	258	323	52	95
Voiding efficiency	12.2%	39.8%	8.5%	36.2%	0.0%	10.5%	64.7%	100%	0.0%	54.4%	7.3%	14.8%	96.2%	100%
Post-void residual (ml)	180	127	150	90	440	335	25	0	160	155	330	350	2	0
Sensation of fullness	No	No	No	No	No	No	No	No	Yes	Yes	Yes	Yes	No	Yes
Sensation of detrusor contraction	No	No	No	Yes	No	Yes	No	No	No	Yes	No	No	No	No
Detrusor-sphincter dyssenergia	Yes	No	Yes	No	Yes	No	Yes	No	Yes	No	Yes	No	Yes	No
Maximum change in Pdet during voiding (cm of H20)	36	65	45	45	NA	31	113	90	NA	51	34	20.7	114	56
Maximum change in Pura during voiding (cm of H20)	92	−44	−2	11	NA	−30	40	−15	NA	7	8.2	−11	77	−53

LUT, Lower Urinary Tract; CIC, Clean intermittent catheterization, Sup, Suppository; DS, Digital Stimulation.

Note the green boxes identify parameters that demonstrate a positive change with TESSLA On compared to TESSLA Off, whereas the red boxes identify parameters that demonstrate a negative change.